Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian CancerTimothy R. Rebbeck, Saundra S. Buys, Fei Wan et al.|JAMA|2015Cited by 507
Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer.G. R. Hudes, C McAleer, Faith E. Nathan et al.|Journal of Clinical Oncology|1997Cited by 273
The Metastatic/Examined Lymph Node Ratio is an Important Prognostic Factor after Pancreaticoduodenectomy for Pancreatic AdenocarcinomaAdam C. Berger, John P. Hoffman, James C. Watson et al.|The American Surgeon|2004Cited by 214
Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic AdenocarcinomaAdam C. Berger, John P. Hoffman, Ingrid M. Meszoely et al.|Annals of Surgical Oncology|2004Cited by 131
Facilitating Informed Decisions Regarding Microsatellite Instability Testing Among High-Risk Individuals Diagnosed With Colorectal CancerSharon L. Manne, Daniel C. Chung, Neal J. Meropol et al.|Journal of Clinical Oncology|2010Cited by 47